mes-impy
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2006 (NCT00407576)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Amyloid beta A4 proteinBINDING AGENT
APP binding agent
Chemistry & pharmacology
- Imaging
- 11-carbon
Oral
No
Parenteral
No
Topical
No
Also known as
- (11c)mes-impy
- mes-impy
- mes-impy
- mes-impy
- n,n-dimethyl-4-(6-(methylthio)imidazo(1,2-a)pyridine-2-yl)aniline
- (s-methyl-11c)n,n-dimethyl-4-(6-(methylthio)imidazo(1,2-a)pyridine-2-yl)aniline
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00407576 | Phase 1 | Dec 1, 2006 | National Institute of Mental Health (NIMH) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Mental Health (NIMH) | Government | 1 | 1 | 1 | 2006 |
1 organizations
Page 1 / 1